Ottoboni Sara, Coleman Simon J, Steven Christopher, Siddique Mariam, Fraissinet Marine, Joannes Marion, Laux Audrey, Barton Alastair, Firth Paul, Price Chris J, Mulheran Paul A
EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation, University of Strathclyde, Glasgow G1 1RD, U.K.
Department of Chemical & Process Engineering, University of Strathclyde, Level 4, James Weir Building, 75 Montrose Street, G1 1XQ Glasgow, U.K.
Org Process Res Dev. 2020 Nov 20;24(11):2505-2520. doi: 10.1021/acs.oprd.0c00035. Epub 2020 Oct 16.
Developing a continuous isolation process to produce a pure, dry, free-flowing active pharmaceutical ingredient (API) is the final barrier to the implementation of continuous end-to-end pharmaceutical manufacturing. Recent work has led to the development of continuous filtration and washing prototypes for pharmaceutical process development and small-scale manufacture. Here, we address the challenge of static drying of a solvent-wet crystalline API in a fixed bed to facilitate the design of a continuous filter dryer for pharmaceutical development, without excessive particle breakage or the formation of interparticle bridges leading to lump formation. We demonstrate the feasibility of drying small batches on a time scale suitable for continuous manufacturing, complemented by the development of a drying model that provides a design tool for process development. We also evaluate the impact of alternative washing and drying approaches on particle agglomeration. We conclude that our approach yields effective technology, with a performance that is amenable to predictive modeling.
开发一种连续分离工艺以生产纯净、干燥、易流动的活性药物成分(API)是实现连续端到端制药生产的最后一道障碍。近期的工作已促成了用于制药工艺开发和小规模生产的连续过滤和洗涤原型的开发。在此,我们应对在固定床中对溶剂湿润的结晶API进行静态干燥的挑战,以促进用于制药开发的连续过滤干燥器的设计,同时避免过多的颗粒破碎或形成导致结块的颗粒间桥连。我们证明了在适合连续生产的时间尺度上干燥小批量产品的可行性,并开发了一个干燥模型作为工艺开发的设计工具。我们还评估了替代洗涤和干燥方法对颗粒团聚的影响。我们得出结论,我们的方法产生了有效的技术,其性能适合进行预测建模。